Fluorimetric quantitation of citalopram and escitalopram in plasma: Developing an express method to monitor compliance in clinical trials

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 4, 2007, Pages 513-520

  Serebruany, Victor ^a,b   Malinin, Alex ^a   Dragan, Vadim ^c   Atar, Dan ^d   Van Zyl, Louis ^e   Dragan, Anatoly ^b  

^a HeartDrug Research Laboratories   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^d AKER UNIVERSITY HOSPITAL   (Norway)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Citalopram; Drug plasma levels; Escitalopram; Fluorimetry; Quantification

Indexed keywords

CELLULOSE; CITALOPRAM; ESCITALOPRAM; PROTEIN;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CENTRIFUGATION; CONCENTRATION (PARAMETERS); CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; FLUOROMETRY; HUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; SPECTROFLUOROMETRY; THAWING;

CITALOPRAM; CLINICAL TRIALS; GUIDELINE ADHERENCE; HUMANS; HYDROGEN-ION CONCENTRATION; SEROTONIN UPTAKE INHIBITORS; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET;

ANIMALIA;

EID: 34247343741     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.108     Document Type: Article

References (42)

1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
2. Regier DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993;50:85-94.
3. DeVane CL. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol 1999;19:443-66.
4. Joubert AF, Sanchez C, Larsen F. Citalopram. Human Psychopharmacol Clin Exp 2000;15:439-51.
5. Larsen JJ, Hyttel J. 5-HT-uptake inhibition potentiates antinociception induced by morphine, pethidine, methadone and ketobemidone in rats. Acta Pharmacol Toxicol (Copenh) 1985;57:214-8.
6. Joffe P, Larsen FS, Pedersen V, Ring-Larsen H, Anes-Jorgensen T, Sidhu J. Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects. Eur J Clin Pharmacol 1998;54:237-42.
7. Priskorn M, Larsen F, Segonzac A, Moulin M. Pharmacokinetic interaction study of citalopram and cimetidine in healthy subjects. Eur J Clin Pharmacol 1997;52:241-2.
8. Oyehaug E, Ostensen ET, Salvesen B. High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients. J Chromatogr 1984;308:199-208.
9. Baumann P, Rochat B. Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror. Int Clin Psychopharmacol 1995;10 (Suppl 1):15-21.
10. Hyttel J. Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 1982;6:277-95.
11. Herrlin K, Yasui-Furukori N, Tybring G, Widen J, Gustafsson LL, Bertilsson L. Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes. Br J Clin Pharmacol 2003;56:415-21.
12. von Moltke LL, Greenblatt DJ, Giancarlo GM, Granda BW, Harmatz JS, Shader RL. Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to Rcitalopram. Drug Metab Dispos 2001;29:1102-9.
13. Waugh J, Goa KL. Escitalopram: a review of its use in the management of major depressive and anxiety disorders. CNS Drugs 2003;17:343-62.
14. Berzas-Nevado JJ, Villasenor-Llerena MJ, Guiberteau-Cabanillas C, Rodriguez-Robledo V. Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study. Electrophoresis 2006;27:905-17.
15. Eap CB, Baumann P. Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients. J Chromatogr B Biomed Appl 1996;686:51-63.
16. Frahnert C, Rao ML, Grasmader K. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring. J Chromatogr B Analyt Technol Biomed Life Sci 2003;794:35-47.
17. Kosel M, Eap CB, Amey M, Baumann P. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography. J Chromatogr B Biomed Sci Appl 1998;719:234-8.
18. Olesen OV, Linnet K. Simplified high-performance liquid chromatographic method for the determination of citalopram and desmethylcitalopram in serum without interference from commonly used psychotropic drugs and their metabolites. J Chromatogr B Biomed Appl 1996;675:83-8.
19. Tournel G, Houdret N, Hedouin V, Deveau M, Gosset D, Lhermitte M. High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum. J Chromatogr B Biomed Sci Appl 2001;761:147-58.
20. Akerman KK, Jolkkonen J, Huttunen H, Penttila I. Highperformance liquid chromatography method for analyzing citalopram and desmethylcitalopram from human serum. Ther Drug Monit 1998;20:25-9.
21. Duverneuil C, de la Grandmaison GL, de Mazancourt P, Alvarez JC. A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs. Ther Drug Monit 2003;25:565-73.
22. Titier K, Castaing N, Scotto-Gomez E, Pehourcq F, Moore N, Molimard M. High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new anti-depressants and five of their active metabolites in plasma after overdose. Ther Drug Monit 2003;25:581-7.
23. Matsui E, Hoshino M, Matsui A, Okahira A. Simultaneous determination of citalopram and its metabolites by high-performance liquid chromatography with column switching and fluorescence detection by direct plasma injection. J Chromatogr B Biomed Appl 1995;668:299-307.
24. Ohman D, Carlsson B, Norlander B. On-line extraction using an alkyl-diol silica precolumn for racemic citalopram and its metabolites in plasma. Results compared with solid-phase extraction methodology. J Chromatogr B Biomed Sci Appl 2001;753:365-73.
25. Rochat B, Amey M, Baumann P. Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography. Ther Drug Monit 1995;17:273-9.
26. Rochat B, Amey M, Van Gelderen H, Testa B, Baumann P. Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC. Chirality 1995;7:389-95.
27. Labat L, Deveaux M, Dallet P, Dubost JP. Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2002;773:17-23.
28. Maurer HH, Bickeboeller-Friedrich J. Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry. J Anal Toxicol 2000;24:340-7.
29. Muller C, Vogt S, Goerke R, Kordon A, Weinmann W. Identification of selected psychopharmaceuticals and their metabolites in hair by LC/ESI-CID/MS and LC/MS/ MS. Forensic Sci Int 2000;113:415-21.
30. Halvorsen TG, Pedersen-Bjergaard S, Rasmussen KE. Liquid-phase microextraction and capillary electrophoresis of citalopram, an antidepressant drug. J Chromatogr A 2001;909:87-93.
31. Andersen S, Halvorsen TG, Pedersen-Bjergaard S, Rasmussen KE, Tanum L, Refsum H. Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis and liquid-phase microextraction. J Pharm Biomed Anal 2003;33:263-73.
32. Eap CB, Bouchoux G, Amey M, Cochard M, Savary L, Baumann P. Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry. J Chromatogr Sci 1998;36:365-71.
33. Jemal M, Ouyang Z, Powell ML. A strategy for a postmethod-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/ tandem mass-spectrometric method for quantitation of drugs in biological samples. Rapid Commun Mass Spectrom 2002;16:1538-47.
34. Kebarle P. A brief overview of the present status of the mechanisms involved in electrospray mass spectrometry. J Mass Spectrom 2000;35:804-17.
35. Lee MS, Kerns EH. LC/MS applications in drug development. Mass Spectrom Rev 1999;18:187-279.
36. Pistos C, Koutsopoulou M, Panderi I. A validated liquid chromatographic tandem mass spectrometric method for the determination of mirtazapine and demethylmirtazapine in human plasma: application to a pharmacokinetic study. Anal Chim Acta 2004;514:15-26.
37. Vishwanathan K, Bartlett MG, Stewart JT. Determination of gatifloxacin in human plasma by liquid chromatography/ electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom 2001;15:915-9.
38. Abian J, Oosterkamp AJ, Gelpi E. Comparison of conventional, narrow-bore and capillary liquid chromatography mass spectrometry for electrospray ionization mass spectrometry: practical considerations. J Mass Spectrom 1999;34:244-54.
39. Macek J, Ptacek P, Klima J. Rapid determination of citalopram in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2001;755:279-85.
40. Massaroti P, Cassiano NM, Duarte LF, Campos DR, Marchieretto MA, Bernasconi G, et al. Validation of a selective method for determination of paroxetine in human plasma by LC-MS/MS. J Pharm Pharm Sci 2005;8:340-7.
41. Meng QH, Gauthier D. Simultaneous analysis of citalopram and desmethylcitalopram by liquid chromatography with fluorescence detection after solid-phase extraction. Clin Biochem 2005;38:282-5.
42. Pistos C, Panderi I, Atta-Politou J. Liquid chromatography-positive ion electrospray mass spectrometry method for the quantification of citalopram in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2004;810:235-44.